ReviewLeukemia & lymphoma2016
Use of class I histone deacetylase inhibitor romidepsin in combination regimens.
Adam Petrich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ReviewLeukemia & lymphoma2016
Adam Petrich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.